Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |